Nan Shan Life Insurance’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $57M | Hold |
939,759
| – | – | 2.06% | 15 |
|
|
2025
Q4 | $50.7M | Hold |
939,759
| – | – | 1.56% | 17 |
|
|
2025
Q3 | $42.4M | Sell |
939,759
-1,760
| -0.2% | -$82.2K | 0.9% | 35 |
|
|
2025
Q2 | $43.6M | Sell |
941,519
-2,077
| -0.2% | -$102K | 0.97% | 30 |
|
|
2025
Q1 | $57.5M | Hold |
943,596
| – | – | 1.36% | 19 |
|
|
2024
Q4 | $53.4M | Sell |
943,596
-338,032
| -26% | -$18.9M | 1.28% | 21 |
|
|
2024
Q3 | $66.3M | Sell |
1,281,628
-21,029
| -2% | -$986K | 1.56% | 16 |
|
|
2024
Q2 | $54.1M | Sell |
1,302,657
-28,296
| -2% | -$1.27M | 1.28% | 19 |
|
|
2024
Q1 | $72.2M | Hold |
1,330,953
| – | – | 1.7% | 11 |
|
|
2023
Q4 | $68.3M | Hold |
1,330,953
| – | – | 1.65% | 16 |
|
|
2023
Q3 | $77.2M | Buy |
1,330,953
+122,707
| +10% | +$7.52M | 2.11% | 9 |
|
|
2023
Q2 | $77.3M | Buy |
1,208,246
+290,835
| +32% | +$19.5M | 1.86% | 11 |
|
|
2023
Q1 | $63.6M | Buy |
917,411
+322,044
| +54% | +$22.7M | 1.51% | 16 |
|
|
2022
Q4 | $42.8M | Sell |
595,367
-574,984
| -49% | -$43.4M | 1.17% | 25 |
|
|
2022
Q3 | $83.2M | Buy |
1,170,351
+609,064
| +109% | +$44.2M | 2.03% | 11 |
|
|
2022
Q2 | $43.2M | Sell |
561,287
-997,521
| -64% | -$76M | 0.91% | 36 |
|
|
2022
Q1 | $114M | Hold |
1,558,808
| – | – | 1.99% | 11 |
|
|
2021
Q4 | $97.2M | Buy |
1,558,808
+326,893
| +27% | +$19.2M | 1.47% | 21 |
|
|
2021
Q3 | $72.9M | Buy |
1,231,915
+270,115
| +28% | +$17.8M | 1.21% | 29 |
|
|
2021
Q2 | $64.3M | Sell |
961,800
-305,807
| -24% | -$19.9M | 1.09% | 35 |
|
|
2021
Q1 | $80M | Hold |
1,267,607
| – | – | 1.55% | 16 |
|
|
2020
Q4 | $78.6M | Hold |
1,267,607
| – | – | 1.63% | 17 |
|
|
2020
Q3 | $76.4M | Buy |
1,267,607
+219,100
| +21% | +$13.2M | 2.01% | 15 |
|
|
2020
Q2 | $61.7M | Buy |
1,048,507
+155,381
| +17% | +$9.29M | 1.87% | 16 |
|
|
2020
Q1 | $49.8M | Hold |
893,126
| – | – | 1.82% | 17 |
|
|
2019
Q4 | $57.3M | Buy |
893,126
+163,419
| +22% | +$9.36M | 1.79% | 17 |
|
|
2019
Q3 | $37M | Sell |
729,707
-7,000
| -1% | -$329K | 1.02% | 34 |
|
|
2019
Q2 | $33.4M | Sell |
736,707
-2,000
| -0.3% | -$93.2K | 0.85% | 43 |
|
|
2019
Q1 | $35.2M | Sell |
738,707
-48,000
| -6% | -$2.39M | 0.69% | 43 |
|
|
2018
Q4 | $40.9M | Sell |
786,707
-87,200
| -10% | -$4.69M | 0.98% | 35 |
|
|
2018
Q3 | $54.3M | Sell |
873,907
-20,000
| -2% | -$1.19M | 1.05% | 30 |
|
|
2018
Q2 | $49.5M | Sell |
893,907
-160,000
| -15% | -$8.64M | 1.14% | 30 |
|
|
2018
Q1 | $66.7M | Hold |
1,053,907
| – | – | 1.36% | 24 |
|
|
2017
Q4 | $64.6M | Hold |
1,053,907
| – | – | 1.67% | 21 |
|
|
2017
Q3 | $67.2M | Sell |
1,053,907
-440,000
| -29% | -$25.7M | 1.39% | 26 |
|
|
2017
Q2 | $83.2M | Hold |
1,493,907
| – | – | 2.12% | 17 |
|
|
2017
Q1 | $81.2M | Hold |
1,493,907
| – | – | 2.03% | 20 |
|
|
2016
Q4 | $87.3M | Hold |
1,493,907
| – | – | 3.31% | 9 |
|
|
2016
Q3 | $80.6M | Buy |
1,493,907
+590,000
| +65% | +$37.9M | 2.33% | 12 |
|
|
2016
Q2 | $66.5M | Sell |
903,907
-351,383
| -28% | -$24.8M | 2.57% | 10 |
|
|
2016
Q1 | $80.2M | Buy |
1,255,290
+100,107
| +9% | +$6.31M | 3.48% | 8 |
|
|
2015
Q4 | $79.5M | Buy |
1,155,183
+529,463
| +85% | +$35M | 4.55% | 6 |
|
|
2015
Q3 | $37M | Sell |
625,720
-42,280
| -6% | -$2.68M | 2.04% | 8 |
|
|
2015
Q2 | $44.4M | Buy |
668,000
+180,000
| +37% | +$11.9M | 2.39% | 8 |
|
|
2015
Q1 | $31.5M | Buy |
488,000
+162,000
| +50% | +$10.1M | 2.22% | 14 |
|
|
2014
Q4 | $19.2M | Sell |
326,000
-235,506
| -42% | -$13.3M | 2.36% | 15 |
|
|
2014
Q3 | $28.7M | Sell |
561,506
-174,713
| -24% | -$8.73M | 3.68% | 12 |
|
|
2014
Q2 | $35.7M | Sell |
736,219
-152,781
| -17% | -$7.53M | 4.72% | 5 |
|
|
2014
Q1 | $46.2M | Buy |
889,000
+10,000
| +1% | +$532K | 7.67% | 1 |
|
|
2013
Q4 | $46.7M | Buy |
879,000
+184,000
| +26% | +$9.37M | 10.64% | 1 |
|
|
2013
Q3 | $32.2M | Buy |
695,000
+132,000
| +23% | +$5.79M | 6.38% | 5 |
|
|
2013
Q2 | $25.2M | Buy |
+563,000
| New | +$24.4M | 9.32% | 6 |
|
Other funds holding BMY
VCM
VPM
Nan Shan Life Insurance's BMY Position: Q1 2026 in Review
Nan Shan Life Insurance held its Bristol-Myers Squibb (BMY) position steady in Q1 2026 at 939,759 shares worth $57M. The position accounts for 2.06% of the portfolio, ranked #15.
Nan Shan Life Insurance first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $114M in Q1 2022. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Nan Shan Life Insurance held 939,759 shares of Bristol-Myers Squibb worth $57M as of Q1 2026.
- Nan Shan Life Insurance left its Bristol-Myers Squibb share count unchanged in Q1 2026.
- Bristol-Myers Squibb made up 2.06% of Nan Shan Life Insurance's portfolio in Q1 2026, its #15 holding.
- Nan Shan Life Insurance first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
- Nan Shan Life Insurance's Bristol-Myers Squibb position peaked at $114M in Q1 2022.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Nan Shan Life Insurance's 13F filing for Q1 2026, filed 14 May 2026.